Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
NVIDIA
NVDA
|
$1.23B |
| 2 |
Merck
MRK
|
$1B |
| 3 |
Abbott
ABT
|
$991M |
| 4 |
Gilead Sciences
GILD
|
$966M |
| 5 |
Amazon
AMZN
|
$920M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$2.75B |
| 2 |
Morgan Stanley
MS
|
$909M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$881M |
| 4 |
Charles Schwab
SCHW
|
$734M |
| 5 |
Arista Networks
ANET
|
$726M |
Sector Composition
| 1 | Healthcare | 22.51% |
| 2 | Technology | 19.45% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 10.07% |
| 5 | Consumer Discretionary | 9.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Exelon
EXC
$44.1B
| $3.7B | 0.7% | 90,844,170 -2,936,685 | -3% | -$120M |
|
27
Chubb
CB
$110B
| $3.54B | 0.67% | 18,384,271 +470,329 | +3% | +$90.6M |
|
28
AstraZeneca
AZN
$248B
| $3.52B | 0.67% | 49,134,415 -3,520,087 | -7% | -$252M |
|
29
HCA Healthcare
HCA
$94.5B
| $3.33B | 0.63% | 10,960,076 -1,935,280 | -15% | -$587M |
|
|
30
Abbott
ABT
$231B
| $3.26B | 0.62% | 29,910,492 +9,090,340 | +44% | +$991M |
|
31
Elevance Health
ELV
$71.8B
| $3.25B | 0.62% | 7,326,113 -1,130,951 | -13% | -$502M |
|
32
Alphabet (Google) Class C
GOOG
$2.58T
| $3.22B | 0.61% | 26,637,577 +3,545,753 | +15% | +$429M |
|
33
Accenture
ACN
$162B
| $3.18B | 0.6% | 10,314,019 -461,615 | -4% | -$142M |
|
34
Nike
NKE
$114B
| $3.16B | 0.6% | 28,655,755 -3,524,830 | -11% | -$389M |
|
35
General Dynamics
GD
$87.3B
| $3.14B | 0.6% | 14,605,250 +721,693 | +5% | +$155M |
|
|
36
Morgan Stanley
MS
$240B
| $3.1B | 0.59% | 36,263,266 -10,644,075 | -23% | -$909M |
|
37
Humana
HUM
$36.5B
| $3.06B | 0.58% | 6,848,706 -499,305 | -7% | -$223M |
|
38
EOG Resources
EOG
$68.2B
| $2.94B | 0.56% | 25,674,202 -1,223,211 | -5% | -$140M |
|
39
Johnson Controls International
JCI
$69.9B
| $2.86B | 0.54% | 41,934,863 -6,890,276 | -14% | -$470M |
|
40
Linde
LIN
$224B
| $2.82B | 0.54% | 7,411,046 -495,583 | -6% | -$189M |
|
41
Marsh & McLennan
MMC
$101B
| $2.75B | 0.52% | 14,631,859 +77,814 | +0.5% | +$14.6M |
|
42
S&P Global
SPGI
$167B
| $2.69B | 0.51% | 6,698,728 +1,577,012 | +31% | +$632M |
|
43
Vertex Pharmaceuticals
VRTX
$100B
| $2.66B | 0.5% | 7,552,894 +35,346 | +0.5% | +$12.4M |
|
44
Northrop Grumman
NOC
$84.5B
| $2.65B | 0.5% | 5,814,991 -199,153 | -3% | -$90.8M |
|
45
Salesforce
CRM
$245B
| $2.63B | 0.5% | 12,449,525 -1,684,645 | -12% | -$356M |
|
46
Colgate-Palmolive
CL
$67.9B
| $2.62B | 0.5% | 34,043,784 -1,213,766 | -3% | -$93.5M |
|
47
Coca-Cola
KO
$297B
| $2.59B | 0.49% | 42,954,362 -11,974,287 | -22% | -$721M |
|
48
Advanced Micro Devices
AMD
$264B
| $2.57B | 0.49% | 22,541,689 +2,286,804 | +11% | +$260M |
|
49
Becton Dickinson
BDX
$55.3B
| $2.55B | 0.48% | 9,659,461 -166,969 | -2% | -$44.1M |
|
50
Progressive
PGR
$145B
| $2.5B | 0.47% | 18,888,054 +570,748 | +3% | +$75.5M |
|